Literature DB >> 9809419

The ability of probiotic bacteria to bind to human intestinal mucus.

P V Kirjavainen1, A C Ouwehand, E Isolauri, S J Salminen.   

Abstract

Human mucus was isolated from faecal samples of newborns, two and six month old infants and adults. The adhesion to this mucus by the bacteria mentioned below was assessed in vitro. Depending on the age group: 44-46% of the applied Lactobacillus GG, 23-30% of Bifidobacterium lactis Bb-12, 9-14% of Lactobacillus johnsonii LJ-1, 3-10% of Lactobacillus salivarius LM2-118, Lactobacillus crispatus M247, Lactobacillus paracasei F19 and 2% of L. crispatus Mu5 adhered. All the strains adhered better to the mucus of adults than to that of infants. With some of the strains significant differences between the infant age groups were also observed. In conclusion, the age of the target group may be worthy of consideration when planning a schedule for probiotic or functional food therapy.

Entities:  

Mesh:

Year:  1998        PMID: 9809419     DOI: 10.1111/j.1574-6968.1998.tb13226.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  51 in total

1.  Probiotics in the Treatment of Diarrheal Diseases.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-02       Impact factor: 3.725

Review 2.  Mucinases and sialidases: their role in the pathogenesis of sexually transmitted infections in the female genital tract.

Authors:  R Wiggins; S J Hicks; P W Soothill; M R Millar; A P Corfield
Journal:  Sex Transm Infect       Date:  2001-12       Impact factor: 3.519

3.  Comparative survival rates of human-derived probiotic Lactobacillus paracasei and L. salivarius strains during heat treatment and spray drying.

Authors:  G E Gardiner; E O'Sullivan; J Kelly; M A Auty; G F Fitzgerald; J K Collins; R P Ross; C Stanton
Journal:  Appl Environ Microbiol       Date:  2000-06       Impact factor: 4.792

4.  In vitro adhesion and platelet aggregation properties of bacteremia-associated lactobacilli.

Authors:  P V Kirjavainen; E M Tuomola; R G Crittenden; A C Ouwehand; D W Harty; L F Morris; H Rautelin; M J Playne; D C Donohue; S J Salminen
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

5.  Biological reduction of aflatoxin B1 in yogurt by probiotic strains of Lactobacillus acidophilus and Lactobacillus rhamnosus.

Authors:  Fatemeh Mosallaie; Hossein Jooyandeh; Mohammad Hojjati; Ali Fazlara
Journal:  Food Sci Biotechnol       Date:  2019-12-23       Impact factor: 2.391

Review 6.  Do probiotics have a therapeutic role in gastroenterology?

Authors:  Jimmy K Limdi; Catherine O'Neill; John McLaughlin
Journal:  World J Gastroenterol       Date:  2006-09-14       Impact factor: 5.742

7.  GroEL of Lactobacillus johnsonii La1 (NCC 533) is cell surface associated: potential role in interactions with the host and the gastric pathogen Helicobacter pylori.

Authors:  Gabriela E Bergonzelli; Dominique Granato; Raymond D Pridmore; Laure F Marvin-Guy; Dominique Donnicola; Irène E Corthésy-Theulaz
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

8.  Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection.

Authors:  M Juntunen; P V Kirjavainen; A C Ouwehand; S J Salminen; E Isolauri
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

9.  Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans.

Authors:  C N Jacobsen; V Rosenfeldt Nielsen; A E Hayford; P L Møller; K F Michaelsen; A Paerregaard; B Sandström; M Tvede; M Jakobsen
Journal:  Appl Environ Microbiol       Date:  1999-11       Impact factor: 4.792

10.  Auto-aggregation and co-aggregation ability in bifidobacteria and clostridia.

Authors:  E Vlková; V Rada; M Smehilová; J Killer
Journal:  Folia Microbiol (Praha)       Date:  2008-07-27       Impact factor: 2.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.